EMERGING THERAPEUTIC STRATEGIES FOR CORONAVIRUS DISEASE 2019

S WAHAB - The Novel Coronavirus, 2023 - books.google.com
This new pandemic has prompted the global scientific community to investigate the biology
and epidemiology of the disease and to create effective treatments as soon as possible …

[PDF][PDF] An overview of treatment options for COVID-19

MM Mohapatra, M Rajaram, DP Dwivedi… - International Journal of …, 2020 - core.ac.uk
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) which emerged in Wuhan
initially as pneumonia of unknown origin in December 2019, later spread to whole world and …

Updated approaches against SARS-CoV-2

H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …

[HTML][HTML] Treatment options for COVID-19: a review

MJ Ali, M Hanif, MA Haider, MU Ahmed… - Frontiers in …, 2020 - frontiersin.org
Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …

[HTML][HTML] Emerging therapeutics in the management of COVID-19

A Kichloo, M Albosta, A Kumar, M Aljadah… - World Journal of …, 2021 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019, COVID-
19) pandemic has placed a tremendous burden on healthcare systems globally …

Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019

A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …

Emerging therapeutics for the management of COVID 19

SK Debnath, R Srivastava, A Omri - Expert Opinion on Emerging …, 2020 - Taylor & Francis
ABSTRACT Introduction The coronavirus-19 (COVID-19) disease pandemic can be
characterized as the most critical and changeable hazard to healthcare systems in eras. The …

Evolving pharmaceutical therapies for confronting COVID-19: An overview

R Ghai, K Nagarajan, T Mishra, S Vats… - AIP Conference …, 2022 - pubs.aip.org
December 2019 was marked by the arrival of the novel coronavirus, which has now
reportedly resulted in 4,200,412 deaths (as ofJuly 30, 2021) world-wide. Although the …

Pharmacological strategies for COVID-19-A review of the most promising repurposed antiviral drugs

D Chopra, JK Boparai, B Bhandari… - … Current Drug Targets …, 2021 - ingentaconnect.com
A novel coronavirus, SARS-CoV-2 (2019-nCoV), emerged in December 2019 as an
immediate global challenge. Comprehensive efforts at the present time are focused …

[HTML][HTML] Recent Insights into Advances of COVID-19 Treatment

P Nivrutti - pharmashots.com
The current century has witnessed the universal spread of the unknown species of
coronaviruses. The rapid deterioration of the public health system with changes in ecology …